NEW YORK, June 1, 2023 /PRNewswire/ — Levi & Korsinsky notifies investors that it has commenced an investigation of Reata Pharmaceuticals, Inc. (“Reata”) (NASDAQ: RETA) concerning possible violations of federal securities laws. On May 10, 2023, Reata issued a press release announcing its financial results for the first quarter of…Read More
RETA Levi Korsinsky LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of Reata Pharmaceuticals Inc MarketScreener
